“…Recently, Yang et al, identified HAND2-AS1 as a potential biomarker for HCC tumorigenesis and metastasis [ 75 ]. Similarly, high expression levels of CASC15 [ 175 ], CYTOR (also known as Linc00152 ) [ 174 ], HANR [ 176 ], ICR (ICAM-1-Related ncRNA) [ 177 ], linc-UFC1 [ 166 ], lncRNA-ATB [ 170 ], lncSHRG [ 178 ], MVIH [ 179 ], PANDAR [ 180 ], PCAT14 [ 181 ], SNHG6 [ 182 ], SNHG20 [ 183 ], TINCR [ 184 ], TMCC1-AS1 [ 72 ], UBE2CP3 [ 185 ], WRAP53 [ 116 ]], ZEB1-AS1 [ 186 ], as well as the downregulation of LOC728290 [ 187 ], GAS5 [ 188 ], DILC [ 189 ], or WT1-AS [ 190 ], have been variably shown to be correlated with clinical severity, aggressive pathological features, metastasis, and/or poor outcome in HCC patients ( Table S1 ). However, it should be noted that given that lncRNA is a fairly young research field, many of these associations have thus far been reported in single studies.…”